Ivosidenib (AG-120) in Mutant IDH1 Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase 1 Study
DiNardo, Courtney D., Stein, Eytan M., de Botton, Stéphane, Roboz, Gail J., Altman, Jessica K., Mims, Alice S., Swords, Ronan, Collins, Robert H., Mannis, Gabriel N., Pollyea, Daniel A., Donnellan, WiVolume:
18
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2018.07.057
Date:
September, 2018
File:
PDF, 84 KB
english, 2018